What’s the Analyst Recommendation for Co-Diagnostics Inc. (CODX)?

Maxim Group announced it was Upgrade coverage of Co-Diagnostics Inc. in a research note on May 20, 2020. H.C. Wainwright rated the stock as a Buy in a research noted published on May 18, 2020. H.C. Wainwright rated the stock as a Buy in a research note published on March 09, 2020.

SERBIN RICHARD S, the Director of Co-Diagnostics Inc., sold 25000.0 shares at the valuation of $18.02 during an exchange that occurred on May 28, which implies that SERBIN RICHARD S is holding 0 shares at the estimation of $450,525.

In another transaction, on May 26, Director of Co-Diagnostics Inc., Durenard Eugene, sold 25000.0 shares at the price of $18.26. After this activity, Durenard Eugene now keeps 0 shares of Co-Diagnostics Inc., esteemed at $456,500.

CODX Recent Trade

The share price of CODX ascended by $0.99 during the exchanging session on 10/02/20 to exchange at $13.96. Co-Diagnostics Inc. stock has an exchanging volume of 6.45 million shares, which is high, contrasted with its 3-months average volume of 4.03M shares. Its market capitalization has now reached to $364.22M.

CODX Past Trading Activity

The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, CODX price has dropped by -2.65%. In the course of past three months sees the stock go down around -22.74%, while it has gain 70.24% over the past six months and 1459.43% since the start of the year.

CODX Earning History

Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Sep 2020), the firm recorded a revenue of 24.04 billion, which was higher than the gauge of 32.79M made by certain experts. For that equivalent quarter, Co-Diagnostics Inc. posted $0.43 earnings per share (EPS) which was underneath the consensus estimate of $0.59 by -$0.16, which represents to a reduction by -27.10%.

CODX Price Performance

Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Co-Diagnostics Inc. has seen its stock exchanging -54.95% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +72.99% above its three-month low. A more extensive look sees CODX exchanging -54.95% beneath its 52-week high and 1549.53% above from its 52-week low price.

CODX Instability & Beta Factor

The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 7.93%, while it has a month to month instability of 12.85%. The company has an ATR (Average True Range) of 1.36.

Leave a Comment